Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities
Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities

Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities

From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent.

Kiran Shroff Article rating: 3.3

From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent.

Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split!
Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split!

Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split!

From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years.

Kiran Shroff Article rating: 4.6

From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years.

Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside!
Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside!

Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside!

From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years.

Kiran Shroff Article rating: 3.7

From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years.

RSS
1234

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR